Silencing oncogene expression in cervical cancer stem-like cells inhibits their cell growth and self-renewal ability (Q39476902)

12 September 2017

Silencing oncogene expression in cervical cancer stem-like cells inhibits their cell growth and self-renewal ability (English)

1 reference

12 September 2017

cervix uterine cancer

1 reference

W Gu

1

1 reference

12 September 2017

E Yeo

series ordinal

2

1 reference

12 September 2017

N McMillan

series ordinal

3

1 reference

12 September 2017

C Yu

series ordinal

4

1 reference

12 September 2017

9 September 2011

1 reference

12 September 2017

1 reference

12 September 2017

18

1 reference

12 September 2017

897-905

1 reference

12 September 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1038/cgt.2011.58

12 September 2017

0 references

cites work

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Enhanced MDR1 expression and chemoresistance of cancer stem cells derived from glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Targeted therapy for cancer stem cells: the patched pathway and ABC transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Modulation of HIV-1 replication by RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Gene silencing by lentivirus-mediated delivery of siRNA in human CD34+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

A status report on RNAi therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Blocking oncogenes in malignant cells by RNA interference--new hope for a highly specific cancer treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

RNA interference in biology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Inhibition of cervical cancer cell growth in vitro and in vivo with lentiviral-vector delivered short hairpin RNA targeting human papillomavirus E6 and E7 oncogenes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Silencing of hdm2 oncogene by siRNA inhibits p53-dependent human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Papillomaviruses and cancer: from basic studies to clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Highly potent and specific siRNAs against E6 or E7 genes of HPV16- or HPV18-infected cervical cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Short-term induction and long-term suppression of HPV16 oncogene silencing by RNA interference in cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Both treated and untreated tumors are eliminated by short hairpin RNA-based induction of target-specific immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

let-7 regulates self renewal and tumorigenicity of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Cancer stem cells from colorectal cancer-derived cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Every single cell clones from cancer cell lines growing tumors in vivo may not invalidate the cancer stem cell concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

The crosstalk of RAS with the TGF-β family during carcinoma progression and its implications for targeted cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

New regulatory mechanisms of TGF-beta receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Roles of TGF-beta family signaling in stem cell renewal and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

The E7 protein from human papillomavirus type 16 enhances keratinocyte migration in an Akt-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

The TGF-beta, PI3K/Akt and PTEN pathways: established and proposed biochemical integration in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Ras alters epithelial-mesenchymal transition in response to TGFbeta by reducing actin fibers and cell-matrix adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Tumour stem cells and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Human Papillomavirus Type 16 E7 Up-regulates AKT Activity through the Retinoblastoma Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

Stem cell-like cancer cells in cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

inferred from DOI database lookup

7 January 2021

based on heuristic

RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

inferred from DOI database lookup

7 January 2021

based on heuristic

Differential expression of transforming growth factors-beta1, -beta2 and -beta3 in human colon carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2011.58

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CGT.2011.58

1 reference

Dimensions Publication ID

12 September 2017

1009455112

0 references

Fatcat ID

release_w6gjdspvhzhc5ec2qb24pwp3gy

0 references

1 reference